4503 — Astellas Pharma Balance Sheet
0.000.00%
Last trade - 00:00HealthcareConservativeLarge CapHigh Flyer
- ¥4tn
- ¥4tn
- ¥2tn
- 98
- 28
- 83
- 83
Annual balance sheet for Astellas Pharma, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2019 March 31st | C2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Yuho | Yuho | Yuho | Yuho | Tanshin |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 311,074 | 324,943 | 326,128 | 318,267 | 396,624 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 365,348 | 373,505 | 362,722 | 423,018 | 445,778 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 857,159 | 867,514 | 872,588 | 923,354 | 1,049,954 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 173,483 | 268,600 | 264,623 | 269,044 | 286,459 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 1,897,648 | 2,315,169 | 2,273,628 | 2,332,395 | 2,456,518 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 497,665 | 798,708 | 592,372 | 687,411 | 726,034 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 639,252 | 1,026,001 | 887,513 | 872,087 | 948,564 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 1,258,396 | 1,289,168 | 1,386,115 | 1,460,308 | 1,507,954 |
| Total Liabilities & Shareholders' Equity | 1,897,648 | 2,315,169 | 2,273,628 | 2,332,395 | 2,456,518 |
| Total Common Shares Outstanding |